These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

281 related articles for article (PubMed ID: 7905257)

  • 1. Striatal D2 dopamine receptor characteristics in neuroleptic-naive schizophrenic patients studied with positron emission tomography.
    Hietala J; Syvälahti E; Vuorio K; Någren K; Lehikoinen P; Ruotsalainen U; Räkköläinen V; Lehtinen V; Wegelius U
    Arch Gen Psychiatry; 1994 Feb; 51(2):116-23. PubMed ID: 7905257
    [TBL] [Abstract][Full Text] [Related]  

  • 2. D2 dopamine receptors in neuroleptic-naive schizophrenic patients. A positron emission tomography study with [11C]raclopride.
    Farde L; Wiesel FA; Stone-Elander S; Halldin C; Nordström AL; Hall H; Sedvall G
    Arch Gen Psychiatry; 1990 Mar; 47(3):213-9. PubMed ID: 1968328
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Measurement of striatal D2 dopamine receptor density and affinity with [11C]-raclopride in vivo: a test-retest analysis.
    Hietala J; Någren K; Lehikoinen P; Ruotsalainen U; Syvälahti E
    J Cereb Blood Flow Metab; 1999 Feb; 19(2):210-7. PubMed ID: 10027776
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Positron emission tomography finding of a high striatal D2 receptor occupancy in olanzapine-treated patients.
    Nordström AL; Nyberg S; Olsson H; Farde L
    Arch Gen Psychiatry; 1998 Mar; 55(3):283-4. PubMed ID: 9510228
    [No Abstract]   [Full Text] [Related]  

  • 5. Dopamine D2 receptor density estimates in schizophrenia: a positron emission tomography study with 11C-N-methylspiperone.
    Tune LE; Wong DF; Pearlson G; Strauss M; Young T; Shaya EK; Dannals RF; Wilson AA; Ravert HT; Sapp J
    Psychiatry Res; 1993 Dec; 49(3):219-37. PubMed ID: 7909948
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Positron emission tomography study of human narcolepsy: no increase in striatal dopamine D2 receptors.
    Rinne JO; Hublin C; Partinen M; Ruottinen H; Ruotsalainen U; Någren K; Lehikoinen P; Laihinen A
    Neurology; 1995 Sep; 45(9):1735-8. PubMed ID: 7675236
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Decrease in human striatal dopamine D2 receptor density with age: a PET study with [11C]raclopride.
    Rinne JO; Hietala J; Ruotsalainen U; Säkö E; Laihinen A; Någren K; Lehikoinen P; Oikonen V; Syvälahti E
    J Cereb Blood Flow Metab; 1993 Mar; 13(2):310-4. PubMed ID: 8436624
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dopamine D2 and D3 receptor occupancy in normal humans treated with the antipsychotic drug aripiprazole (OPC 14597): a study using positron emission tomography and [11C]raclopride.
    Yokoi F; Gründer G; Biziere K; Stephane M; Dogan AS; Dannals RF; Ravert H; Suri A; Bramer S; Wong DF
    Neuropsychopharmacology; 2002 Aug; 27(2):248-59. PubMed ID: 12093598
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Striatal dopamine D2 receptor density in neuroleptic-naive and in neuroleptic-free schizophrenic patients: an 123I-IBZM-SPECT study.
    Lomeña F; Catafau AM; Parellada E; Bernardo M; Font M; Gutiérrez F; Pavía J
    Psychopharmacology (Berl); 2004 Mar; 172(2):165-9. PubMed ID: 14624330
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Striatal D2 dopamine receptor binding characteristics in vivo in patients with alcohol dependence.
    Hietala J; West C; Syvälahti E; Någren K; Lehikoinen P; Sonninen P; Ruotsalainen U
    Psychopharmacology (Berl); 1994 Nov; 116(3):285-90. PubMed ID: 7892418
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Sex differences in the striatal dopamine D2 receptor binding characteristics in vivo.
    Pohjalainen T; Rinne JO; Någren K; Syvälahti E; Hietala J
    Am J Psychiatry; 1998 Jun; 155(6):768-73. PubMed ID: 9619148
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Striatal vs extrastriatal dopamine D2 receptors in antipsychotic response--a double-blind PET study in schizophrenia.
    Agid O; Mamo D; Ginovart N; Vitcu I; Wilson AA; Zipursky RB; Kapur S
    Neuropsychopharmacology; 2007 Jun; 32(6):1209-15. PubMed ID: 17077809
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antipsychotic-associated mental side effects and their relationship to dopamine D2 receptor occupancy in striatal subdivisions: a high-resolution PET study with [11C]raclopride.
    Kim JH; Son YD; Kim HK; Lee SY; Cho SE; Kim YB; Cho ZH
    J Clin Psychopharmacol; 2011 Aug; 31(4):507-11. PubMed ID: 21694619
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The estimated density of D2 striatal receptors in schizophrenia. A study with positron emission tomography and 76Br-bromolisuride.
    Martinot JL; Paillère-Martinot ML; Loc'h C; Hardy P; Poirier MF; Mazoyer B; Beaufils B; Mazière B; Allilaire JF; Syrota A
    Br J Psychiatry; 1991 Mar; 158():346-50. PubMed ID: 1827999
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Measuring age-related changes in dopamine D2 receptors with 11C-raclopride and 18F-N-methylspiroperidol.
    Volkow ND; Wang GJ; Fowler JS; Logan J; Gatley SJ; MacGregor RR; Schlyer DJ; Hitzemann R; Wolf AP
    Psychiatry Res; 1996 May; 67(1):11-6. PubMed ID: 8797238
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [123I]IBZM SPECT for imaging of striatal D2 dopamine receptors in 56 schizophrenic patients taking various neuroleptics.
    Klemm E; Grünwald F; Kasper S; Menzel C; Broich K; Danos P; Reichmann K; Krappel C; Rieker O; Briele B; Hotze AL; Möller HJ; Biersack HJ
    Am J Psychiatry; 1996 Feb; 153(2):183-90. PubMed ID: 8561197
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Central D2-dopamine receptor occupancy in relation to antipsychotic drug effects: a double-blind PET study of schizophrenic patients.
    Nordström AL; Farde L; Wiesel FA; Forslund K; Pauli S; Halldin C; Uppfeldt G
    Biol Psychiatry; 1993 Feb; 33(4):227-35. PubMed ID: 8097114
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The current status of PET scanning with respect to schizophrenia.
    Sedvall G
    Neuropsychopharmacology; 1992 Aug; 7(1):41-54. PubMed ID: 1388021
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Test-retest reliability of central [11C]raclopride binding at high D2 receptor occupancy. A PET study in haloperidol-treated patients.
    Nyberg S; Farde L; Halldin C
    Psychiatry Res; 1996 Oct; 67(3):163-71. PubMed ID: 8912956
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Affinity States of Striatal Dopamine D2 Receptors in Antipsychotic-Free Patients with Schizophrenia.
    Kubota M; Nagashima T; Takano H; Kodaka F; Fujiwara H; Takahata K; Moriguchi S; Kimura Y; Higuchi M; Okubo Y; Takahashi H; Ito H; Suhara T
    Int J Neuropsychopharmacol; 2017 Nov; 20(11):928-935. PubMed ID: 29016872
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.